Industries across the U.S. continue to implement environmental, social and governance (ESG) initiatives, and the Pharmaceutical-Biotech Industry is no exception. The industry's ESG-related projects are buoyed by adherence to Leadership in Energy and Environmental Design (LEED) guidelines that ensure facilities are built with a multitude of "green" features.
With the U.S. expected to see up to 36.4 gigawatts (GW) of utility-scale solar generation added to its power grid in 2024, fueled partly by improving supply chains and easing trade restrictions, some of the top states for the energy resource are preparing to notch up major project kickoffs.
Despite facing challenges from foreign competition, particularly from countries with lower labor costs, the U.S. shipbuilding industry maintains its position as a world leader in innovation, quality and capability.
On March 13, at 10 a.m. CDT (11 a.m. EDT), Industrial Info will be holding a complimentary webinar on the outlook for the refining, crude oil and alternative fuels sectors.